197 related articles for article (PubMed ID: 6089056)
1. Experimental basis for the antidepressant action of the GABA receptor agonist progabide.
Bartholini G
Neurosci Lett; 1984 Jun; 47(3):351-5. PubMed ID: 6089056
[TBL] [Abstract][Full Text] [Related]
2. Pharmacology of the GABAergic system: effects of progabide, a GABA receptor agonist.
Bartholini G
Psychoneuroendocrinology; 1984; 9(2):135-40. PubMed ID: 6089242
[TBL] [Abstract][Full Text] [Related]
3. GABA receptor agonists: pharmacological spectrum and therapeutic actions.
Bartholini G
Med Res Rev; 1985; 5(1):55-75. PubMed ID: 2984490
[TBL] [Abstract][Full Text] [Related]
4. gamma-Aminobutyric acid (GABA) receptor stimulation. III. Effect of progabide (SL 76002) on norepinephrine, dopamine and 5-hydroxytryptamine turnover in rat brain areas.
Scatton B; Zivkovic B; Dedek J; Lloyd KG; Constantinidis J; Tissot R; Bartholini G
J Pharmacol Exp Ther; 1982 Mar; 220(3):678-88. PubMed ID: 6278130
[No Abstract] [Full Text] [Related]
5. gamma-Aminobutyric acid (GABA) receptor stimulation. II. Specificity of progabide (SL 76002) and SL 75102 for the GABA receptor.
Lloyd KG; Arbilla S; Beaumont K; Briley M; De Montis G; Scatton B; Langer SZ; Bartholini G
J Pharmacol Exp Ther; 1982 Mar; 220(3):672-7. PubMed ID: 6121050
[TBL] [Abstract][Full Text] [Related]
6. Depression and antidepressant therapy: receptor dynamics.
Zemlan FP; Garver DL
Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(4):503-23. PubMed ID: 2173022
[TBL] [Abstract][Full Text] [Related]
7. gamma-Aminobutyric acid (GABA) receptor stimulation. I. Neuropharmacological profiles of progabide (SL 76002) and SL 75102, with emphasis on their anticonvulsant spectra.
Worms P; Depoortere H; Durand A; Morselli PL; Lloyd KG; Bartholini G
J Pharmacol Exp Ther; 1982 Mar; 220(3):660-71. PubMed ID: 6278129
[TBL] [Abstract][Full Text] [Related]
8. [Implications of GABAergic synapses in neuropsychiatry].
Lloyd KG; Perrault G; Zivkovic B
J Pharmacol; 1985; 16 Suppl 2():5-27. PubMed ID: 2867252
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological and therapeutic actions of GABA receptor agonists.
Zivkovic B; Scatton B; Worms P; Lloyd KG; Bartholini G
J Neural Transm Suppl; 1983; 18():319-26. PubMed ID: 6308150
[TBL] [Abstract][Full Text] [Related]
10. The potential use of GABA agonists in psychiatric disorders: evidence from studies with progabide in animal models and clinical trials.
Lloyd KG; Morselli PL; Depoortere H; Fournier V; Zivkovic B; Scatton B; Broekkamp C; Worms P; Bartholini G
Pharmacol Biochem Behav; 1983 Jun; 18(6):957-66. PubMed ID: 6351106
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of chronic antidepressants in behavioural tests of beta-adrenergic and GABAB receptor function.
McManus DJ; Greenshaw AJ
Psychopharmacology (Berl); 1991; 103(2):204-8. PubMed ID: 1851308
[TBL] [Abstract][Full Text] [Related]
12. Some anticonvulsant drugs alter monoamine-mediated behaviour in mice in ways similar to electroconvulsive shock; implications for antidepressant therapy.
Green AR; Johnson P; Mountford JA; Nimgaonkar VL
Br J Pharmacol; 1985 Feb; 84(2):337-46. PubMed ID: 2983809
[TBL] [Abstract][Full Text] [Related]
13. Fengabine, a novel antidepressant GABAergic agent. II. Effect on cerebral noradrenergic, serotonergic and GABAergic transmission in the rat.
Scatton B; Lloyd KG; Zivkovic B; Dennis T; Claustre Y; Dedek J; Arbilla S; Langer SZ; Bartholini G
J Pharmacol Exp Ther; 1987 Apr; 241(1):251-7. PubMed ID: 3033204
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of gamma-aminobutyric acid (GABA) B binding sites in rat frontal cortex: a common action of repeated administration of different classes of antidepressants and electroshock.
Lloyd KG; Thuret F; Pilc A
J Pharmacol Exp Ther; 1985 Oct; 235(1):191-9. PubMed ID: 2995646
[TBL] [Abstract][Full Text] [Related]
15. Noradrenergic rather than GABAergic processes as the common mediation of the antidepressant profile of GABA agonists and imipramine-like drugs in animals.
Poncelet M; Martin P; Danti S; Simon P; Soubrié P
Pharmacol Biochem Behav; 1987 Nov; 28(3):321-6. PubMed ID: 3685065
[TBL] [Abstract][Full Text] [Related]
16. gamma-Aminobutyric acid (GABA) receptor stimulation. IV. Effect of progabide (SL 76002) and other GABAergic agents on acetylcholine turnover in rat brain areas.
Scatton B; Bartholini G
J Pharmacol Exp Ther; 1982 Mar; 220(3):689-95. PubMed ID: 6278131
[No Abstract] [Full Text] [Related]
17. The psychopharmacology of GABA synapses: update 1989.
Lloyd KG; Pichat P; Scatton B; Zivkovic B; Morselli PL; Bartholini G
J Neural Transm Suppl; 1990; 29():13-28. PubMed ID: 2162909
[TBL] [Abstract][Full Text] [Related]
18. Bupropion: a review of its mechanism of antidepressant activity.
Ascher JA; Cole JO; Colin JN; Feighner JP; Ferris RM; Fibiger HC; Golden RN; Martin P; Potter WZ; Richelson E
J Clin Psychiatry; 1995 Sep; 56(9):395-401. PubMed ID: 7665537
[TBL] [Abstract][Full Text] [Related]
19. Antidepressants and serotonergic neurotransmission: an integrative review.
Willner P
Psychopharmacology (Berl); 1985; 85(4):387-404. PubMed ID: 2410942
[TBL] [Abstract][Full Text] [Related]
20. Neonatal treatment with monoamine uptake inhibitors alters later response in behavioural 'despair' test to beta and GABA-B receptor agonists.
Hilakivi LA; Taira T; Hilakivi I; Loikas P
Pharmacol Toxicol; 1988 Jul; 63(1):57-61. PubMed ID: 2969507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
